Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.38606563 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.33256771 |
3 | synaptic vesicle maturation (GO:0016188) | 5.94418570 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.92029070 |
5 | vocalization behavior (GO:0071625) | 5.65786023 |
6 | synaptic vesicle exocytosis (GO:0016079) | 5.55281436 |
7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.53019255 |
8 | epithelial cell fate commitment (GO:0072148) | 5.48958082 |
9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.42350649 |
10 | locomotory exploration behavior (GO:0035641) | 5.36711248 |
11 | protein localization to synapse (GO:0035418) | 5.34048215 |
12 | glutamate secretion (GO:0014047) | 5.21345925 |
13 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.15195495 |
14 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.14151913 |
15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.13477069 |
16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.12274687 |
17 | glycerophospholipid catabolic process (GO:0046475) | 4.91713674 |
18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.72123017 |
19 | neuronal action potential propagation (GO:0019227) | 4.71613125 |
20 | glutamate receptor signaling pathway (GO:0007215) | 4.64340385 |
21 | regulation of synaptic vesicle transport (GO:1902803) | 4.54945737 |
22 | synaptic transmission, glutamatergic (GO:0035249) | 4.49470663 |
23 | adaptation of signaling pathway (GO:0023058) | 4.47079586 |
24 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.46273622 |
25 | exploration behavior (GO:0035640) | 4.45227540 |
26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.39780243 |
27 | neuron cell-cell adhesion (GO:0007158) | 4.30244407 |
28 | neurotransmitter secretion (GO:0007269) | 4.29676977 |
29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.29541551 |
30 | neuron-neuron synaptic transmission (GO:0007270) | 4.27451419 |
31 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.25534755 |
32 | positive regulation of membrane potential (GO:0045838) | 4.23063825 |
33 | dendritic spine morphogenesis (GO:0060997) | 4.21959137 |
34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.19325417 |
35 | layer formation in cerebral cortex (GO:0021819) | 4.19239177 |
36 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.18725754 |
37 | regulation of synapse structural plasticity (GO:0051823) | 4.16929307 |
38 | positive regulation of synapse maturation (GO:0090129) | 4.14773056 |
39 | regulation of synaptic plasticity (GO:0048167) | 4.13352539 |
40 | insulin secretion (GO:0030073) | 4.03429740 |
41 | regulation of postsynaptic membrane potential (GO:0060078) | 4.03066593 |
42 | long-term synaptic potentiation (GO:0060291) | 4.01598714 |
43 | respiratory chain complex IV assembly (GO:0008535) | 4.01485274 |
44 | long-term memory (GO:0007616) | 3.96913702 |
45 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.89914894 |
46 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.89522349 |
47 | positive regulation of dendritic spine development (GO:0060999) | 3.84856899 |
48 | cellular ketone body metabolic process (GO:0046950) | 3.84314675 |
49 | regulation of dendritic spine development (GO:0060998) | 3.72680157 |
50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.71976650 |
51 | regulation of vesicle fusion (GO:0031338) | 3.70294631 |
52 | behavioral defense response (GO:0002209) | 3.67709891 |
53 | behavioral fear response (GO:0001662) | 3.67709891 |
54 | cytochrome complex assembly (GO:0017004) | 3.65209414 |
55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.64931033 |
56 | regulation of glutamate secretion (GO:0014048) | 3.64750511 |
57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.62859037 |
58 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.61669461 |
59 | neuron recognition (GO:0008038) | 3.57496383 |
60 | endocrine pancreas development (GO:0031018) | 3.57140969 |
61 | transmission of nerve impulse (GO:0019226) | 3.56434400 |
62 | dendritic spine organization (GO:0097061) | 3.55656481 |
63 | alanine transport (GO:0032328) | 3.55633050 |
64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.51134855 |
65 | cellular potassium ion homeostasis (GO:0030007) | 3.50173238 |
66 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.49360774 |
67 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.47289201 |
68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.47147718 |
69 | fear response (GO:0042596) | 3.46698844 |
70 | endothelial cell chemotaxis (GO:0035767) | 3.44544078 |
71 | neuromuscular process controlling posture (GO:0050884) | 3.42700274 |
72 | regulation of neurotransmitter secretion (GO:0046928) | 3.42298916 |
73 | activation of protein kinase A activity (GO:0034199) | 3.42051942 |
74 | gamma-aminobutyric acid transport (GO:0015812) | 3.41079856 |
75 | neuromuscular process controlling balance (GO:0050885) | 3.41059115 |
76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.40374816 |
77 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.38169996 |
78 | synaptic vesicle endocytosis (GO:0048488) | 3.36142654 |
79 | regulation of female receptivity (GO:0045924) | 3.35289596 |
80 | neurotransmitter transport (GO:0006836) | 3.35195756 |
81 | detection of calcium ion (GO:0005513) | 3.34635576 |
82 | ketone body metabolic process (GO:1902224) | 3.33445873 |
83 | behavioral response to cocaine (GO:0048148) | 3.30523916 |
84 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28969297 |
85 | regulation of neurotransmitter uptake (GO:0051580) | 3.27495175 |
86 | positive regulation of insulin secretion (GO:0032024) | 3.26637333 |
87 | negative regulation of amino acid transport (GO:0051956) | 3.26474674 |
88 | membrane depolarization (GO:0051899) | 3.26361428 |
89 | long term synaptic depression (GO:0060292) | 3.26216507 |
90 | auditory receptor cell differentiation (GO:0042491) | 3.25746109 |
91 | response to histamine (GO:0034776) | 3.25663582 |
92 | learning (GO:0007612) | 3.24816586 |
93 | chemosensory behavior (GO:0007635) | 3.23634776 |
94 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.18064482 |
95 | positive regulation of gluconeogenesis (GO:0045722) | 3.17971692 |
96 | regulation of neurotransmitter levels (GO:0001505) | 3.16766942 |
97 | regulation of gonadotropin secretion (GO:0032276) | 3.16554413 |
98 | regulation of synaptic transmission (GO:0050804) | 3.14231853 |
99 | regulation of neurotransmitter transport (GO:0051588) | 3.13934990 |
100 | positive regulation of synaptic transmission (GO:0050806) | 3.13356541 |
101 | regulation of synapse maturation (GO:0090128) | 3.12913250 |
102 | behavioral response to nicotine (GO:0035095) | 3.12855214 |
103 | postsynaptic membrane organization (GO:0001941) | 3.11889805 |
104 | auditory behavior (GO:0031223) | 3.11409630 |
105 | proline transport (GO:0015824) | 3.09458967 |
106 | presynaptic membrane assembly (GO:0097105) | 3.09235287 |
107 | axonal fasciculation (GO:0007413) | 3.09112757 |
108 | mating behavior (GO:0007617) | 3.08303870 |
109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06484088 |
110 | response to amphetamine (GO:0001975) | 3.05450732 |
111 | dentate gyrus development (GO:0021542) | 3.05185099 |
112 | synaptic transmission, dopaminergic (GO:0001963) | 3.04986952 |
113 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.04896854 |
114 | female mating behavior (GO:0060180) | 3.03724385 |
115 | neuronal ion channel clustering (GO:0045161) | 3.03617115 |
116 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.03482344 |
117 | synaptic transmission (GO:0007268) | 3.03183505 |
118 | * cellular response to gonadotropin stimulus (GO:0071371) | 3.01041613 |
119 | regulation of action potential (GO:0098900) | 3.00771434 |
120 | membrane hyperpolarization (GO:0060081) | 3.00415962 |
121 | positive regulation of action potential (GO:0045760) | 2.99821639 |
122 | positive regulation of meiosis (GO:0045836) | 2.99211445 |
123 | sodium ion export (GO:0071436) | 2.98847540 |
124 | inositol phosphate catabolic process (GO:0071545) | 2.98744130 |
125 | prepulse inhibition (GO:0060134) | 2.98390855 |
126 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.96327670 |
127 | peptide hormone secretion (GO:0030072) | 2.95799923 |
128 | innervation (GO:0060384) | 2.94642736 |
129 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.93549639 |
130 | regulation of glucokinase activity (GO:0033131) | 2.91763545 |
131 | regulation of hexokinase activity (GO:1903299) | 2.91763545 |
132 | presynaptic membrane organization (GO:0097090) | 2.89840929 |
133 | inositol phosphate dephosphorylation (GO:0046855) | 2.88849475 |
134 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.88849475 |
135 | peptide secretion (GO:0002790) | 2.84427527 |
136 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.84211709 |
137 | regulation of insulin secretion (GO:0050796) | 2.83310389 |
138 | serotonin metabolic process (GO:0042428) | 2.81112290 |
139 | signal release (GO:0023061) | 2.79827290 |
140 | negative regulation of dendrite development (GO:2000171) | 2.78790228 |
141 | astrocyte differentiation (GO:0048708) | 2.78635973 |
142 | response to gravity (GO:0009629) | 2.76888076 |
143 | zinc ion homeostasis (GO:0055069) | 2.76364977 |
144 | protein localization to cilium (GO:0061512) | 2.74799089 |
145 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.72892368 |
146 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.71754165 |
147 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.71754165 |
148 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.70048979 |
149 | neuromuscular synaptic transmission (GO:0007274) | 2.69798937 |
150 | positive regulation of peptide hormone secretion (GO:0090277) | 2.67425314 |
151 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.62194831 |
152 | positive regulation of peptide secretion (GO:0002793) | 2.61209740 |
153 | type B pancreatic cell development (GO:0003323) | 2.60715806 |
154 | L-phenylalanine catabolic process (GO:0006559) | 2.60668436 |
155 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60668436 |
156 | primary amino compound metabolic process (GO:1901160) | 2.58631534 |
157 | protein targeting to Golgi (GO:0000042) | 2.57896157 |
158 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.57653510 |
159 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.56801235 |
160 | regulation of peptide hormone secretion (GO:0090276) | 2.56042921 |
161 | neuron fate specification (GO:0048665) | 2.55693673 |
162 | nitric oxide biosynthetic process (GO:0006809) | 2.55220071 |
163 | adrenergic receptor signaling pathway (GO:0071875) | 2.52353997 |
164 | regulation of peptide secretion (GO:0002791) | 2.51251142 |
165 | response to corticosterone (GO:0051412) | 2.50771771 |
166 | regulation of oxidative phosphorylation (GO:0002082) | 2.50233798 |
167 | platelet dense granule organization (GO:0060155) | 2.49413245 |
168 | protein localization to Golgi apparatus (GO:0034067) | 2.46226525 |
169 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46031262 |
170 | response to dietary excess (GO:0002021) | 2.45816312 |
171 | catecholamine transport (GO:0051937) | 2.45636326 |
172 | sex determination (GO:0007530) | 2.45127824 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.75085050 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.83554182 |
3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.28366536 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.25457308 |
5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.25415493 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25003906 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.21293647 |
8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90756777 |
9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.86203189 |
10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.86203189 |
11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.82246427 |
12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.79258605 |
13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67196771 |
14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63991202 |
15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63548574 |
16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.62106390 |
17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59698953 |
18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56426952 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47773552 |
20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.42925256 |
21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.42431357 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.38744530 |
23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.38591401 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37636456 |
25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.34303120 |
26 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24367115 |
27 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99055153 |
28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92227449 |
29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80742759 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73738787 |
31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72160216 |
32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70688549 |
33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69481897 |
34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65623261 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60043853 |
36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55085621 |
37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.54885841 |
38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54242282 |
39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52496305 |
40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47496079 |
41 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.43142973 |
42 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.39408539 |
43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36647708 |
44 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34441831 |
45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33152083 |
46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32273582 |
47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30541744 |
48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28987476 |
49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28580267 |
50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28486207 |
51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28096442 |
52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27293366 |
53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27205816 |
54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25824807 |
55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23526800 |
56 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22993283 |
57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21591748 |
58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20788356 |
59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20093547 |
60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19886569 |
61 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19572140 |
62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19368096 |
63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18954027 |
64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18564351 |
65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18405009 |
66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18340314 |
67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16777549 |
68 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15862989 |
69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15727550 |
70 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15480131 |
71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.12932101 |
72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12436856 |
73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12244486 |
74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12012771 |
75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11885371 |
76 | AR_19668381_ChIP-Seq_PC3_Human | 1.11463657 |
77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11321182 |
78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10720305 |
79 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10476444 |
80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09687408 |
81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09508746 |
82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09097963 |
83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09091338 |
84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08172945 |
85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07258687 |
86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07144520 |
87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06982100 |
88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05789785 |
89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05662389 |
90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04954923 |
91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04954923 |
92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04434161 |
93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04289670 |
94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03871337 |
95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03691887 |
96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02518865 |
97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01585040 |
98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00822919 |
99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00515798 |
100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99643712 |
101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99160774 |
102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98707993 |
103 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97897336 |
104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97897336 |
105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97663936 |
106 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97494472 |
107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96847583 |
108 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96349427 |
109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96331318 |
110 | NCOR_22424771_ChIP-Seq_293T_Human | 0.95750925 |
111 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95215626 |
112 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95159682 |
113 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94318301 |
114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94137002 |
115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93733017 |
116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92876746 |
117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92850857 |
118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92579292 |
119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92549435 |
120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92519678 |
121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91646163 |
122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90316305 |
123 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90103316 |
124 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89875899 |
125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89193618 |
126 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88729519 |
127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88677132 |
128 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88582404 |
129 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88374742 |
130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87119386 |
131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86910582 |
132 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85934463 |
133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83620217 |
134 | JUN_21703547_ChIP-Seq_K562_Human | 0.82178174 |
135 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.80915881 |
136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79256759 |
137 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.78465439 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.17761550 |
2 | MP0003880_abnormal_central_pattern | 4.99692844 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.46991529 |
4 | MP0004270_analgesia | 3.73071654 |
5 | MP0009745_abnormal_behavioral_response | 3.67444577 |
6 | MP0002063_abnormal_learning/memory/cond | 3.63726552 |
7 | MP0002822_catalepsy | 3.48464706 |
8 | MP0002064_seizures | 3.27765621 |
9 | MP0009046_muscle_twitch | 3.21805365 |
10 | MP0002572_abnormal_emotion/affect_behav | 3.02349250 |
11 | MP0001501_abnormal_sleep_pattern | 2.84947958 |
12 | MP0001968_abnormal_touch/_nociception | 2.79929184 |
13 | MP0003195_calcinosis | 2.76667900 |
14 | MP0002272_abnormal_nervous_system | 2.68564295 |
15 | MP0006072_abnormal_retinal_apoptosis | 2.62772328 |
16 | MP0005379_endocrine/exocrine_gland_phen | 2.54940064 |
17 | MP0001486_abnormal_startle_reflex | 2.49980032 |
18 | MP0002163_abnormal_gland_morphology | 2.36699074 |
19 | MP0005423_abnormal_somatic_nervous | 2.35003900 |
20 | MP0008877_abnormal_DNA_methylation | 2.22047571 |
21 | MP0002734_abnormal_mechanical_nocicepti | 2.19575880 |
22 | MP0001440_abnormal_grooming_behavior | 2.16841380 |
23 | MP0002736_abnormal_nociception_after | 2.15654172 |
24 | MP0002254_reproductive_system_inflammat | 2.09915056 |
25 | MP0003011_delayed_dark_adaptation | 2.04142355 |
26 | MP0003329_amyloid_beta_deposits | 2.02044417 |
27 | MP0002735_abnormal_chemical_nociception | 1.97866501 |
28 | MP0003172_abnormal_lysosome_physiology | 1.94449700 |
29 | MP0001944_abnormal_pancreas_morphology | 1.94360765 |
30 | MP0005646_abnormal_pituitary_gland | 1.84412222 |
31 | MP0002693_abnormal_pancreas_physiology | 1.83169394 |
32 | MP0004924_abnormal_behavior | 1.82959146 |
33 | MP0005386_behavior/neurological_phenoty | 1.82959146 |
34 | MP0002557_abnormal_social/conspecific_i | 1.76803495 |
35 | MP0003879_abnormal_hair_cell | 1.74020078 |
36 | MP0008569_lethality_at_weaning | 1.73685154 |
37 | MP0004811_abnormal_neuron_physiology | 1.72660891 |
38 | MP0002067_abnormal_sensory_capabilities | 1.70917511 |
39 | MP0002909_abnormal_adrenal_gland | 1.70891617 |
40 | MP0002733_abnormal_thermal_nociception | 1.68835716 |
41 | MP0001970_abnormal_pain_threshold | 1.67600243 |
42 | MP0003787_abnormal_imprinting | 1.64450292 |
43 | MP0009780_abnormal_chondrocyte_physiolo | 1.64325997 |
44 | MP0002638_abnormal_pupillary_reflex | 1.60433411 |
45 | MP0002184_abnormal_innervation | 1.58191738 |
46 | MP0002102_abnormal_ear_morphology | 1.55566238 |
47 | MP0000778_abnormal_nervous_system | 1.53638637 |
48 | MP0001529_abnormal_vocalization | 1.51300996 |
49 | MP0004858_abnormal_nervous_system | 1.47679737 |
50 | MP0010329_abnormal_lipoprotein_level | 1.47227115 |
51 | MP0004019_abnormal_vitamin_homeostasis | 1.46936152 |
52 | MP0006276_abnormal_autonomic_nervous | 1.40616259 |
53 | MP0001502_abnormal_circadian_rhythm | 1.39557597 |
54 | MP0001984_abnormal_olfaction | 1.36444499 |
55 | MP0002066_abnormal_motor_capabilities/c | 1.34534261 |
56 | MP0002139_abnormal_hepatobiliary_system | 1.34033307 |
57 | MP0000955_abnormal_spinal_cord | 1.32142790 |
58 | MP0001756_abnormal_urination | 1.30501991 |
59 | MP0001188_hyperpigmentation | 1.28468906 |
60 | MP0003633_abnormal_nervous_system | 1.28457731 |
61 | MP0002882_abnormal_neuron_morphology | 1.27310733 |
62 | MP0001905_abnormal_dopamine_level | 1.26901083 |
63 | MP0002078_abnormal_glucose_homeostasis | 1.23735830 |
64 | MP0008961_abnormal_basal_metabolism | 1.22564624 |
65 | MP0005253_abnormal_eye_physiology | 1.17080197 |
66 | MP0003878_abnormal_ear_physiology | 1.16788036 |
67 | MP0005377_hearing/vestibular/ear_phenot | 1.16788036 |
68 | MP0003075_altered_response_to | 1.16202341 |
69 | MP0005448_abnormal_energy_balance | 1.12516009 |
70 | MP0005332_abnormal_amino_acid | 1.12254950 |
71 | MP0003122_maternal_imprinting | 1.11789466 |
72 | MP0003631_nervous_system_phenotype | 1.10967199 |
73 | MP0005220_abnormal_exocrine_pancreas | 1.10713250 |
74 | MP0004885_abnormal_endolymph | 1.09269806 |
75 | MP0005645_abnormal_hypothalamus_physiol | 1.07856495 |
76 | MP0008872_abnormal_physiological_respon | 1.06730559 |
77 | MP0000013_abnormal_adipose_tissue | 1.06595154 |
78 | MP0003953_abnormal_hormone_level | 1.04301449 |
79 | MP0004142_abnormal_muscle_tone | 1.02976958 |
80 | MP0002152_abnormal_brain_morphology | 1.01870131 |
81 | MP0000604_amyloidosis | 1.00451314 |
82 | MP0000751_myopathy | 0.99153792 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.97235021 |
84 | MP0008874_decreased_physiological_sensi | 0.96436518 |
85 | MP0005623_abnormal_meninges_morphology | 0.94439882 |
86 | MP0005409_darkened_coat_color | 0.92834969 |
87 | MP0000569_abnormal_digit_pigmentation | 0.91184104 |
88 | MP0003123_paternal_imprinting | 0.90903146 |
89 | MP0010234_abnormal_vibrissa_follicle | 0.89995785 |
90 | MP0002069_abnormal_eating/drinking_beha | 0.88819518 |
91 | MP0000639_abnormal_adrenal_gland | 0.88124770 |
92 | MP0004484_altered_response_of | 0.87813094 |
93 | MP0005410_abnormal_fertilization | 0.87228403 |
94 | MP0001177_atelectasis | 0.85624665 |
95 | MP0004145_abnormal_muscle_electrophysio | 0.85060545 |
96 | MP0002277_abnormal_respiratory_mucosa | 0.83843517 |
97 | MP0008995_early_reproductive_senescence | 0.82455925 |
98 | MP0004085_abnormal_heartbeat | 0.80971138 |
99 | MP0000538_abnormal_urinary_bladder | 0.80532274 |
100 | MP0004742_abnormal_vestibular_system | 0.80228330 |
101 | MP0003045_fibrosis | 0.78792571 |
102 | MP0002229_neurodegeneration | 0.78394129 |
103 | MP0001765_abnormal_ion_homeostasis | 0.76438783 |
104 | MP0005084_abnormal_gallbladder_morpholo | 0.76056987 |
105 | * MP0003698_abnormal_male_reproductive | 0.75001669 |
106 | MP0003632_abnormal_nervous_system | 0.74145489 |
107 | MP0003283_abnormal_digestive_organ | 0.73681209 |
108 | MP0000003_abnormal_adipose_tissue | 0.72938677 |
109 | MP0005535_abnormal_body_temperature | 0.71664109 |
110 | MP0003690_abnormal_glial_cell | 0.71301579 |
111 | MP0001963_abnormal_hearing_physiology | 0.70676072 |
112 | MP0000372_irregular_coat_pigmentation | 0.70264947 |
113 | MP0004510_myositis | 0.70254034 |
114 | MP0000631_abnormal_neuroendocrine_gland | 0.69242200 |
115 | MP0003890_abnormal_embryonic-extraembry | 0.66406908 |
116 | MP0003634_abnormal_glial_cell | 0.66178353 |
117 | MP0005636_abnormal_mineral_homeostasis | 0.66168864 |
118 | MP0010386_abnormal_urinary_bladder | 0.64914367 |
119 | MP0005058_abnormal_lysosome_morphology | 0.64746411 |
120 | MP0006036_abnormal_mitochondrial_physio | 0.64671678 |
121 | MP0002837_dystrophic_cardiac_calcinosis | 0.64199694 |
122 | MP0006292_abnormal_olfactory_placode | 0.64147862 |
123 | MP0005551_abnormal_eye_electrophysiolog | 0.63305184 |
124 | MP0000920_abnormal_myelination | 0.61890789 |
125 | MP0002876_abnormal_thyroid_physiology | 0.61347484 |
126 | MP0002234_abnormal_pharynx_morphology | 0.61067163 |
127 | MP0001485_abnormal_pinna_reflex | 0.57505727 |
128 | MP0002090_abnormal_vision | 0.57454828 |
129 | MP0004215_abnormal_myocardial_fiber | 0.55464276 |
130 | MP0001664_abnormal_digestion | 0.54954083 |
131 | MP0003121_genomic_imprinting | 0.54232393 |
132 | MP0002752_abnormal_somatic_nervous | 0.53796409 |
133 | MP0005166_decreased_susceptibility_to | 0.51797580 |
134 | MP0005499_abnormal_olfactory_system | 0.51193828 |
135 | MP0005394_taste/olfaction_phenotype | 0.51193828 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.68150375 |
2 | Myokymia (HP:0002411) | 7.41825048 |
3 | Focal seizures (HP:0007359) | 6.07004775 |
4 | Visual hallucinations (HP:0002367) | 5.23314735 |
5 | Epileptic encephalopathy (HP:0200134) | 4.93868674 |
6 | Atonic seizures (HP:0010819) | 4.81183342 |
7 | Febrile seizures (HP:0002373) | 4.45637972 |
8 | Abnormality of the lower motor neuron (HP:0002366) | 4.22883275 |
9 | Absence seizures (HP:0002121) | 4.20016702 |
10 | Generalized tonic-clonic seizures (HP:0002069) | 3.95120819 |
11 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.93815800 |
12 | Dialeptic seizures (HP:0011146) | 3.86468810 |
13 | Progressive cerebellar ataxia (HP:0002073) | 3.64879024 |
14 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.59113226 |
15 | Poor eye contact (HP:0000817) | 3.55861194 |
16 | Anxiety (HP:0000739) | 3.52204770 |
17 | Action tremor (HP:0002345) | 3.50352780 |
18 | Gaze-evoked nystagmus (HP:0000640) | 3.47555868 |
19 | Broad-based gait (HP:0002136) | 3.47343368 |
20 | Hyperventilation (HP:0002883) | 3.42319977 |
21 | Depression (HP:0000716) | 3.39673340 |
22 | Ketoacidosis (HP:0001993) | 3.39252352 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.25153087 |
24 | Amblyopia (HP:0000646) | 3.22675868 |
25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.21155970 |
26 | Dysmetria (HP:0001310) | 3.18365548 |
27 | Intestinal atresia (HP:0011100) | 3.12815896 |
28 | Abnormal social behavior (HP:0012433) | 3.11862922 |
29 | Impaired social interactions (HP:0000735) | 3.11862922 |
30 | Increased CSF protein (HP:0002922) | 3.11694964 |
31 | Dysdiadochokinesis (HP:0002075) | 3.01632212 |
32 | Ankle clonus (HP:0011448) | 2.99954661 |
33 | Supranuclear gaze palsy (HP:0000605) | 2.98543445 |
34 | Poor suck (HP:0002033) | 2.98124309 |
35 | Hypoglycemic coma (HP:0001325) | 2.96455954 |
36 | Abnormality of the corticospinal tract (HP:0002492) | 2.92236101 |
37 | Congenital malformation of the right heart (HP:0011723) | 2.91660909 |
38 | Double outlet right ventricle (HP:0001719) | 2.91660909 |
39 | Amyotrophic lateral sclerosis (HP:0007354) | 2.89968193 |
40 | Polyphagia (HP:0002591) | 2.88632938 |
41 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.86343734 |
42 | Urinary urgency (HP:0000012) | 2.85601594 |
43 | Hyperglycemia (HP:0003074) | 2.85050007 |
44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.83663920 |
45 | Cerebral inclusion bodies (HP:0100314) | 2.80714183 |
46 | Impaired smooth pursuit (HP:0007772) | 2.75970741 |
47 | Large for gestational age (HP:0001520) | 2.75251019 |
48 | Stereotypic behavior (HP:0000733) | 2.72938359 |
49 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.70457161 |
50 | Abnormal eating behavior (HP:0100738) | 2.67769660 |
51 | Vascular calcification (HP:0004934) | 2.66326286 |
52 | Termporal pattern (HP:0011008) | 2.64196768 |
53 | Insidious onset (HP:0003587) | 2.64196768 |
54 | Annular pancreas (HP:0001734) | 2.64139946 |
55 | Abnormal sex determination (HP:0012244) | 2.63910591 |
56 | Sex reversal (HP:0012245) | 2.63910591 |
57 | Spastic gait (HP:0002064) | 2.63106224 |
58 | Absent speech (HP:0001344) | 2.61876523 |
59 | Hypoglycemic seizures (HP:0002173) | 2.60310420 |
60 | Genetic anticipation (HP:0003743) | 2.60283247 |
61 | Postural instability (HP:0002172) | 2.59692479 |
62 | Excessive salivation (HP:0003781) | 2.59572147 |
63 | Drooling (HP:0002307) | 2.59572147 |
64 | Abnormal albumin level (HP:0012116) | 2.58681716 |
65 | Hypoalbuminemia (HP:0003073) | 2.58681716 |
66 | Epileptiform EEG discharges (HP:0011182) | 2.57946267 |
67 | Delusions (HP:0000746) | 2.52552943 |
68 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.52215184 |
69 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.52215184 |
70 | Testicular neoplasm (HP:0010788) | 2.50572609 |
71 | Hepatic necrosis (HP:0002605) | 2.50459375 |
72 | Abnormality of the 1st metacarpal (HP:0010009) | 2.50197470 |
73 | Hypothermia (HP:0002045) | 2.49675683 |
74 | Torticollis (HP:0000473) | 2.49297728 |
75 | Truncal ataxia (HP:0002078) | 2.48880284 |
76 | Hypoplasia of the uterus (HP:0000013) | 2.47239678 |
77 | Focal dystonia (HP:0004373) | 2.44154187 |
78 | Pendular nystagmus (HP:0012043) | 2.43532123 |
79 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.42788416 |
80 | Increased circulating renin level (HP:0000848) | 2.42397541 |
81 | Vacuolated lymphocytes (HP:0001922) | 2.41541868 |
82 | Impaired vibratory sensation (HP:0002495) | 2.41416863 |
83 | EEG with generalized epileptiform discharges (HP:0011198) | 2.40286736 |
84 | Gonadal dysgenesis (HP:0000133) | 2.37931791 |
85 | Neurofibrillary tangles (HP:0002185) | 2.34787569 |
86 | Hepatocellular necrosis (HP:0001404) | 2.34057155 |
87 | Progressive inability to walk (HP:0002505) | 2.31875277 |
88 | Short tibia (HP:0005736) | 2.31582567 |
89 | Hemiparesis (HP:0001269) | 2.30850043 |
90 | Ventricular fibrillation (HP:0001663) | 2.27812518 |
91 | Hypomagnesemia (HP:0002917) | 2.27559028 |
92 | Abnormality of the labia minora (HP:0012880) | 2.26918969 |
93 | Bradykinesia (HP:0002067) | 2.26036628 |
94 | Hypsarrhythmia (HP:0002521) | 2.25380721 |
95 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.24470624 |
96 | Late onset (HP:0003584) | 2.21111689 |
97 | Status epilepticus (HP:0002133) | 2.20396284 |
98 | Mutism (HP:0002300) | 2.19098761 |
99 | Intention tremor (HP:0002080) | 2.17004253 |
100 | Cardiovascular calcification (HP:0011915) | 2.16130906 |
101 | Progressive neurologic deterioration (HP:0002344) | 2.15936711 |
102 | Inability to walk (HP:0002540) | 2.15848670 |
103 | Obstructive sleep apnea (HP:0002870) | 2.15360712 |
104 | Nuclear cataract (HP:0100018) | 2.13629092 |
105 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12818495 |
106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12818495 |
107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12818495 |
108 | Postural tremor (HP:0002174) | 2.12600847 |
109 | Megalencephaly (HP:0001355) | 2.12384206 |
110 | Incomplete penetrance (HP:0003829) | 2.12296220 |
111 | Enlarged penis (HP:0000040) | 2.11592830 |
112 | Scanning speech (HP:0002168) | 2.10922721 |
113 | Thickened helices (HP:0000391) | 2.10694780 |
114 | Pointed chin (HP:0000307) | 2.10352550 |
115 | Polydipsia (HP:0001959) | 2.09996047 |
116 | Abnormal drinking behavior (HP:0030082) | 2.09996047 |
117 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.09086689 |
118 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.09086689 |
119 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.08895274 |
120 | Labial hypoplasia (HP:0000066) | 2.08619175 |
121 | Limb dystonia (HP:0002451) | 2.08616490 |
122 | Ketosis (HP:0001946) | 2.08021251 |
123 | Lower limb muscle weakness (HP:0007340) | 2.07897712 |
124 | Agitation (HP:0000713) | 2.07859933 |
125 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.07817357 |
126 | Craniofacial dystonia (HP:0012179) | 2.07661190 |
127 | Papilledema (HP:0001085) | 2.07193555 |
128 | Generalized myoclonic seizures (HP:0002123) | 2.06568182 |
129 | Decreased circulating renin level (HP:0003351) | 2.05913165 |
130 | Gait ataxia (HP:0002066) | 2.05053849 |
131 | Bundle branch block (HP:0011710) | 2.03523620 |
132 | Dysmetric saccades (HP:0000641) | 2.01778805 |
133 | Resting tremor (HP:0002322) | 1.99733699 |
134 | Pheochromocytoma (HP:0002666) | 1.98292457 |
135 | Large eyes (HP:0001090) | 1.97999950 |
136 | Menstrual irregularities (HP:0000858) | 1.96877554 |
137 | Psychosis (HP:0000709) | 1.96138042 |
138 | Albinism (HP:0001022) | 1.96062949 |
139 | Diplopia (HP:0000651) | 1.95197742 |
140 | Abnormality of binocular vision (HP:0011514) | 1.95197742 |
141 | Epidermoid cyst (HP:0200040) | 1.94081825 |
142 | Abnormality of vitamin B metabolism (HP:0004340) | 1.93524503 |
143 | Muscular hypotonia of the trunk (HP:0008936) | 1.92021935 |
144 | Fetal akinesia sequence (HP:0001989) | 1.91994025 |
145 | Mitochondrial inheritance (HP:0001427) | 1.91564969 |
146 | Tetraplegia (HP:0002445) | 1.91153722 |
147 | Blue irides (HP:0000635) | 1.91063342 |
148 | Severe visual impairment (HP:0001141) | 1.89375715 |
149 | Hemiplegia (HP:0002301) | 1.88717734 |
150 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88497600 |
151 | Sleep apnea (HP:0010535) | 1.88220698 |
152 | Hyperlipoproteinemia (HP:0010980) | 1.87736412 |
153 | Retinal dysplasia (HP:0007973) | 1.87626024 |
154 | Truncus arteriosus (HP:0001660) | 1.85353009 |
155 | Upper limb muscle weakness (HP:0003484) | 1.84994201 |
156 | Mucopolysacchariduria (HP:0008155) | 1.84712499 |
157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84712499 |
158 | Abnormality of vitamin metabolism (HP:0100508) | 1.83795671 |
159 | Generalized hypopigmentation (HP:0007513) | 1.83726980 |
160 | Ankyloglossia (HP:0010296) | 1.83168966 |
161 | Failure to thrive in infancy (HP:0001531) | 1.82299464 |
162 | Progressive macrocephaly (HP:0004481) | 1.82005729 |
163 | Shoulder girdle muscle weakness (HP:0003547) | 1.81743483 |
164 | Lower limb amyotrophy (HP:0007210) | 1.81706266 |
165 | Neoplasm of the heart (HP:0100544) | 1.81690043 |
166 | Abnormal EKG (HP:0003115) | 1.81660038 |
167 | Prominent supraorbital ridges (HP:0000336) | 1.80171322 |
168 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79044418 |
169 | Glycosuria (HP:0003076) | 1.78756209 |
170 | Abnormality of urine glucose concentration (HP:0011016) | 1.78756209 |
171 | Iris hypopigmentation (HP:0007730) | 1.78667535 |
172 | Attenuation of retinal blood vessels (HP:0007843) | 1.78030837 |
173 | Deep palmar crease (HP:0006191) | 1.77120182 |
174 | Rapidly progressive (HP:0003678) | 1.75707790 |
175 | Achilles tendon contracture (HP:0001771) | 1.75535774 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.67689047 |
2 | NTRK3 | 4.53866282 |
3 | MAP3K9 | 4.04896106 |
4 | FRK | 3.93137944 |
5 | MAP4K2 | 2.80067576 |
6 | DAPK2 | 2.77150716 |
7 | KSR2 | 2.66488106 |
8 | MAP3K4 | 2.62062812 |
9 | RIPK4 | 2.61387561 |
10 | PRKD3 | 2.46523483 |
11 | MINK1 | 2.38567235 |
12 | PHKG1 | 2.31288122 |
13 | PHKG2 | 2.31288122 |
14 | MAP2K7 | 2.30795598 |
15 | GRK1 | 2.19940633 |
16 | PAK6 | 2.11515449 |
17 | NTRK2 | 2.07213695 |
18 | MAP3K13 | 2.02529543 |
19 | DAPK1 | 1.99102197 |
20 | MAP2K6 | 1.98052920 |
21 | ARAF | 1.94763295 |
22 | MST4 | 1.89921992 |
23 | KSR1 | 1.83542837 |
24 | PTK2B | 1.76582369 |
25 | MAP3K12 | 1.73643370 |
26 | MAP2K4 | 1.73414854 |
27 | PLK2 | 1.72128970 |
28 | FES | 1.64171910 |
29 | TNIK | 1.62925575 |
30 | NTRK1 | 1.60752095 |
31 | CAMKK1 | 1.59424161 |
32 | TNK2 | 1.52986179 |
33 | CDK5 | 1.52099644 |
34 | MARK1 | 1.46388464 |
35 | PRPF4B | 1.42843169 |
36 | CASK | 1.41137246 |
37 | GRK5 | 1.40743763 |
38 | PNCK | 1.37431499 |
39 | MAP3K2 | 1.37315249 |
40 | NLK | 1.31851936 |
41 | CSNK1G1 | 1.29256521 |
42 | EIF2AK3 | 1.26278137 |
43 | EPHA3 | 1.25174098 |
44 | ADRBK2 | 1.24640989 |
45 | STK38 | 1.23068019 |
46 | RAF1 | 1.20557020 |
47 | TYRO3 | 1.19919654 |
48 | CDK19 | 1.18666474 |
49 | PRKCG | 1.18622855 |
50 | FGFR2 | 1.11160827 |
51 | CSNK1G3 | 1.10392387 |
52 | MAPK13 | 1.10366174 |
53 | BMPR2 | 1.08275979 |
54 | SIK2 | 1.08096593 |
55 | UHMK1 | 1.05493953 |
56 | CAMK2A | 1.05488863 |
57 | CAMK1 | 1.03085805 |
58 | TAOK1 | 1.02454766 |
59 | WNK3 | 0.99331192 |
60 | BMPR1B | 0.98551445 |
61 | TESK1 | 0.97606039 |
62 | CHUK | 0.96935713 |
63 | IRAK1 | 0.94651584 |
64 | RPS6KA5 | 0.94303264 |
65 | MAP3K1 | 0.93307242 |
66 | CAMK2B | 0.92604423 |
67 | MKNK2 | 0.91433442 |
68 | TAOK2 | 0.88187453 |
69 | MAP2K2 | 0.87734085 |
70 | ERBB3 | 0.87643755 |
71 | CDK14 | 0.87565300 |
72 | STK11 | 0.84730961 |
73 | MAP3K5 | 0.83835675 |
74 | IRAK2 | 0.82460897 |
75 | TRIM28 | 0.81700154 |
76 | NME1 | 0.81295813 |
77 | MUSK | 0.80461133 |
78 | CDK18 | 0.80158716 |
79 | CDK15 | 0.78146187 |
80 | CSNK1A1L | 0.77346634 |
81 | FGFR3 | 0.76359000 |
82 | FGR | 0.75412848 |
83 | BRD4 | 0.72491987 |
84 | STK38L | 0.71171963 |
85 | CAMKK2 | 0.70899384 |
86 | NUAK1 | 0.69106266 |
87 | PDK1 | 0.67764528 |
88 | CDK11A | 0.66701809 |
89 | PAK3 | 0.64993737 |
90 | IKBKB | 0.64710271 |
91 | CSNK1A1 | 0.64283345 |
92 | SGK1 | 0.64138446 |
93 | PRKCH | 0.62364391 |
94 | DYRK1A | 0.59956147 |
95 | OXSR1 | 0.59795042 |
96 | FER | 0.59717325 |
97 | PRKCI | 0.59575068 |
98 | INSRR | 0.59267948 |
99 | PDPK1 | 0.59227646 |
100 | SIK3 | 0.59051582 |
101 | PINK1 | 0.56264150 |
102 | LMTK2 | 0.55360846 |
103 | RET | 0.54936815 |
104 | CAMK1D | 0.53783383 |
105 | HIPK2 | 0.50791169 |
106 | MAP2K1 | 0.50656532 |
107 | PRKCQ | 0.50419757 |
108 | CDK3 | 0.50359763 |
109 | ALK | 0.50006061 |
110 | SGK223 | 0.49557890 |
111 | SGK494 | 0.49557890 |
112 | MARK2 | 0.48545049 |
113 | DMPK | 0.47158510 |
114 | TEC | 0.47101152 |
115 | DAPK3 | 0.47001217 |
116 | CCNB1 | 0.46038995 |
117 | CAMK2D | 0.44958589 |
118 | CAMK4 | 0.44792012 |
119 | WNK4 | 0.43630203 |
120 | CSNK1D | 0.42755208 |
121 | RPS6KA3 | 0.42255798 |
122 | LIMK1 | 0.42124491 |
123 | PRKAA1 | 0.41615320 |
124 | BRAF | 0.41444937 |
125 | PRKCZ | 0.41355505 |
126 | BRSK1 | 0.41100398 |
127 | RPS6KA1 | 0.40811363 |
128 | CAMK2G | 0.40712190 |
129 | PRKCE | 0.38316579 |
130 | TLK1 | 0.38286787 |
131 | LATS2 | 0.38248107 |
132 | PDK3 | 0.38046399 |
133 | PDK4 | 0.38046399 |
134 | MOS | 0.37982385 |
135 | PRKD2 | 0.37757359 |
136 | MAPK7 | 0.37312390 |
137 | FYN | 0.36037026 |
138 | MAP3K7 | 0.32593708 |
139 | MAPK12 | 0.32335335 |
140 | MAPK10 | 0.31634834 |
141 | PRKCB | 0.28892857 |
142 | MAPKAPK5 | 0.27496485 |
143 | PRKCA | 0.27373174 |
144 | CSNK1G2 | 0.27345341 |
145 | MAP3K11 | 0.25693682 |
146 | MAPK8 | 0.24665308 |
147 | AKT3 | 0.24447453 |
148 | SGK2 | 0.24244748 |
149 | GRK6 | 0.23441237 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.04605803 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.68388502 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.18854226 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 3.12246034 |
5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.98618801 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.89513440 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.87103830 |
8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73015452 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.60834720 |
10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.56802055 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 2.46431546 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32610267 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.32436008 |
14 | Salivary secretion_Homo sapiens_hsa04970 | 2.25842324 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22364573 |
16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.13190289 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 2.00689029 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.97116826 |
19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93848956 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92762709 |
21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90172720 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.88331527 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.84459232 |
24 | Long-term depression_Homo sapiens_hsa04730 | 1.81994799 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.78049530 |
26 | Protein export_Homo sapiens_hsa03060 | 1.76130853 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74193432 |
28 | Taste transduction_Homo sapiens_hsa04742 | 1.71489402 |
29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69591255 |
30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69348049 |
31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62147564 |
32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.59953951 |
33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56551819 |
34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.45330502 |
35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39950202 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34327367 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34327167 |
38 | Gap junction_Homo sapiens_hsa04540 | 1.32907295 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30227743 |
40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.28533079 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26381739 |
42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22329570 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21316819 |
44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21296155 |
45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20297469 |
46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19932998 |
47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.18993322 |
48 | Melanogenesis_Homo sapiens_hsa04916 | 1.18936192 |
49 | Glioma_Homo sapiens_hsa05214 | 1.18675231 |
50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14809827 |
51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12378619 |
52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12004110 |
53 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.10535560 |
54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09336605 |
55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07758523 |
56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07367431 |
57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03344533 |
58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03206069 |
59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01460614 |
60 | Mineral absorption_Homo sapiens_hsa04978 | 0.99915870 |
61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99264793 |
62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97840857 |
63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97015132 |
64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95614724 |
65 | Axon guidance_Homo sapiens_hsa04360 | 0.95385356 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94583919 |
67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94380530 |
68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92147996 |
69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91961328 |
70 | Peroxisome_Homo sapiens_hsa04146 | 0.89292599 |
71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86074562 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85989382 |
73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83424926 |
74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82843830 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78953935 |
76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78922167 |
77 | Lysosome_Homo sapiens_hsa04142 | 0.77776532 |
78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76889845 |
79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75415913 |
80 | ABC transporters_Homo sapiens_hsa02010 | 0.72352279 |
81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72008050 |
82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71502218 |
83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71117127 |
84 | Phototransduction_Homo sapiens_hsa04744 | 0.70983885 |
85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70750136 |
86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68060769 |
87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67619435 |
88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67286155 |
89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66013005 |
90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65057683 |
91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63204981 |
92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58517200 |
93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56986423 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56861155 |
95 | Prion diseases_Homo sapiens_hsa05020 | 0.56329117 |
96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56175445 |
97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55657164 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55619175 |
99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55103103 |
100 | Alcoholism_Homo sapiens_hsa05034 | 0.52759160 |
101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51579857 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48702119 |
103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48279265 |
104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46283823 |
105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45920671 |
106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43563554 |
107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42930959 |
108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40845096 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.40043188 |
110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39728010 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39550561 |
112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39440585 |
113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39029382 |
114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38543073 |
115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38183788 |
116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37303115 |
117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37258422 |
118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36142230 |
119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35299318 |
120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35018540 |
121 | Bile secretion_Homo sapiens_hsa04976 | 0.34640790 |
122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34322325 |
123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33903477 |
124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33858454 |
125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33240322 |
126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31917111 |
127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31739043 |
128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30087223 |
129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29674659 |
130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29188945 |
131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.28771463 |
132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28431049 |
133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28050028 |
134 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27522653 |
135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26836893 |
136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25816592 |
137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25794512 |
138 | Salmonella infection_Homo sapiens_hsa05132 | 0.25345239 |
139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23253718 |
140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21664526 |